// App-Quantinova.ai

2 : Comparison of hypofractionated high-dose intensity-modulated radiotherapy schedules for prostate cancer: Results from the phase III randomized CHHiP trial (CRUK/06/016).

Researchers

Presenter

  • David P. Dearnaley

Principal Investigators

  • Helen Mossop

  • Alison J. Birtle

  • DJ Bloomfield

  • Clare Cruickshank

  • John Graham

  • Shama Hassan

  • Vincent Khoo

  • John P. Logue

  • Helen Mayles

  • Julian Money-Kyrle

  • Olivia Frances Naismith

  • Miguel Panades

  • Helen Patterson

  • Christopher D Scrase

  • John Staffurth

  • Jean Tremlett

  • Clare Griffin

  • Emma Hall

Medical Centers

  • The Institute of Cancer Research, The Royal Marsden NHS Foundation Trust, Sutton, United Kingdom

  • Clatterbridge Centre for Oncology, Wirral, United Kingdom

  • Royal Marsden Hospital and Institute of Cancer Research, London, United Kingdom

  • Lancashire Teaching Hospitals NHS Foundation Trust, Manchester, United Kingdom

  • Brighton and Sussex University Hospitals NHS Trust, Sussex Cancer Centre, Brighton, United Kingdom

  • Institute of Cancer Research Clinical Trials and Statistics Unit, Sutton, United Kingdom

  • The Royal Marsden Hospital NHS Foundation Trust, London & Surrey, United Kingdom

  • The Christie Hospital, Manchester, United Kingdom

  • Clatterbridge Centre for Oncology, Wirral, United Kingdom

  • Royal Surrey County Hospital, Guildford, United Kingdom

  • Department of Physics, Royal Marsden NHS Foundation Trust, London, United Kingdom

  • Lincoln County Hospital, Lincoln, United Kingdom

  • Addenbrookes Hospital, Cambridge, United Kingdom

  • Ipswich Hospital, Ipswich, United Kingdom

  • Velindre NHS Trust, Cardiff, United Kingdom

  • Brighton and Sussex University Hospitals NHS Trust, Sussex Cancer Centre, Brighton, United Kingdom

  • Institute for Cancer Research, London, United Kingdom

  • The Institute of Cancer Research, Sutton, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Non Inferiority

Phase

  • III

Study Id's

  • ISRCTN97182923

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved